Phio Pharmaceuticals Corp. (PHIO) has 32 open-market insider trades by 5 insiders since 2020. Over the last six months insiders net bought $69K. The most active filer is Robert J. Bitterman, CEO & Chairman +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert J. Bitterman | CEOChairmanPres | — | 17 | $72K | 2026-09-11 |
| Ronald Todd Plott | Dir | — | 2 | $27K | 2026-09-29 |
| Gerrit Dispersyn | Pres | — | 4 | $27K | 2022-03-01 |
| Robert L. Ferrara | Dir | — | 6 | $22K | 2025-09-11 |
| Patricia A. Bradford | CEOChairmanPres | — | 3 | $21K | 2026-09-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ronald Todd Plott | Director | Buy | $10K | 2026-09-28 |
| Patricia A. Bradford | Director | Buy | $7K | 2026-09-24 |
| Patricia A. Bradford | CEO & Chairman +1 | Buy | $2K | 2026-09-22 |
| Patricia A. Bradford | Director | Buy | $12K | 2026-09-15 |
| Ronald Todd Plott | Director | Buy | $17K | 2026-08-19 |
| Robert J. Bitterman | CEO & Chairman +1 | Buy | $11K |
Companies that share insiders with PHIO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-08-18 |
| Robert J. Bitterman | CEO & Chairman +1 | Buy | $10K | 2026-06-26 |
| Robert J. Bitterman | Chairman & Pres. & CEO | Buy | $5K | 2025-12-31 |
| Robert J. Bitterman | Chairman & Pres. & CEO | Buy | $5K | 2025-12-23 |
| Robert J. Bitterman | Chairman & Pres. & CEO | Buy | $6K | 2025-11-21 |
| Robert J. Bitterman | Chairman & Pres. & CEO | Buy | $6K | 2025-11-18 |
| Robert L. Ferrara | Director | Buy | $6K | 2025-06-10 |
| Robert J. Bitterman | Chairman & Pres & CEO | Buy | $5K | 2025-06-10 |
| Robert J. Bitterman | Chairman & Pres & CEO | Buy | $4K | 2025-06-09 |
| Robert J. Bitterman | Chairman & Pres & CEO | Buy | $7K | 2025-05-21 |